{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:13:16Z","timestamp":1778821996129,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81800528"],"award-info":[{"award-number":["81800528"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.intimp.2021.108182","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T23:44:05Z","timestamp":1633045445000},"page":"108182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"PA","title":["The effect of hepatitis B virus on T lymphocyte and its subsets in chronic hepatitis B patients in different ALT stages: A new concept ALT in HBV infection"],"prefix":"10.1016","volume":"101","author":[{"given":"Peng","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanping","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongxia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2021.108182_b0005","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jceh.2015.06.002","article-title":"Emerging Trends in Epidemiology of Hepatitis B Virus Infection","volume":"5","author":"Stasi","year":"2017","journal-title":"J. Clin. Transl. Hepatol."},{"issue":"12","key":"10.1016\/j.intimp.2021.108182_b0010","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1111\/jvh.12938","article-title":"The epidemiology of hepatitis B and hepatitis C infections in China from 2004 to 2014: An observational population-based study","volume":"25","author":"Liu","year":"2018","journal-title":"J. Viral Hepat."},{"issue":"7","key":"10.1016\/j.intimp.2021.108182_b0015","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1136\/archdischild-2016-312043","article-title":"Hepatitis B: changing epidemiology and interventions","volume":"102","author":"Nannini","year":"2017","journal-title":"Arch. Dis. Child."},{"issue":"1","key":"10.1016\/j.intimp.2021.108182_b0020","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/vim.2016.0113","article-title":"Hepatitis B Virus e Antigen Regulates Monocyte Function and Promotes B Lymphocyte Activation","volume":"30","author":"Lu","year":"2017","journal-title":"Viral Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2021.108182_b0025","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1159\/000488272","article-title":"The Influence of B and T Lymphocyte Attenuator Genetic Variants on Susceptibility to Chronic Hepatitis B Virus Infection","volume":"45","author":"Tang","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.intimp.2021.108182_b0030","first-page":"324","article-title":"Hepatitis virus infection in China: a new approach","volume":"12","author":"Wang","year":"2010","journal-title":"Chinese J. Liver Dis."},{"issue":"4","key":"10.1016\/j.intimp.2021.108182_b0035","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s40121-017-0173-y","article-title":"New viral and immunological targets for hepatitis B treatment and cure: a review","volume":"6","author":"Arends","year":"2017","journal-title":"Infect Dis. Ther."},{"issue":"18","key":"10.1016\/j.intimp.2021.108182_b0040","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1016\/j.vaccine.2017.03.049","article-title":"Chronic hepatitis B: immunological profile and current therapeutic vaccines in clinical trials","volume":"35","author":"Lobaina","year":"2017","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.intimp.2021.108182_b0045","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11901-015-0269-3","article-title":"Global epidemiology of Hepatitis B Virus (HBV) infection","volume":"14","author":"Papastergiou","year":"2015","journal-title":"Curr. Hepatol. Rep."},{"key":"10.1016\/j.intimp.2021.108182_b0050","first-page":"1402","article-title":"Recent advances in HBV reactivation research","volume":"26","author":"Guo","year":"2018","journal-title":"Biomed Res. Int."},{"issue":"24","key":"10.1016\/j.intimp.2021.108182_b0055","first-page":"3025","volume":"15","author":"Assy","year":"2009","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.intimp.2021.108182_b0060","unstructured":"Chinese Medical Association Infectious Diseases Branch and Chinese Medical Association Liver Disease Branch. Guidelines for Prevention and Treatment of Chronic Hepatitis B (2019 Edition). J. Clin. Hepatol. 12 (2019) 2648\u20132669."},{"key":"10.1016\/j.intimp.2021.108182_b0065","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-1-4939-6931-9_13","article-title":"Using ex vivo liver organ cultures to measure lymphocyte trafficking","volume":"39","author":"Wiggins","year":"2017","journal-title":"Methods Mol. Biol."},{"issue":"3","key":"10.1016\/j.intimp.2021.108182_b0070","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/lt.25019","article-title":"Hepatocyte-induced CD4+ T cell alloresponse is associated with major histocompatibility complex class II up-regulation on hepatocytes and suppressible by regulatory T cells","volume":"24","author":"DeTemple","year":"2018","journal-title":"Liver Transpl."},{"key":"10.1016\/j.intimp.2021.108182_b0075","unstructured":"Polaris Observatory Collaborators. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol. Hepatol. 3 (2018) 383\u2013403."},{"key":"10.1016\/j.intimp.2021.108182_b0080","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1001\/jama.2018.3795","article-title":"Chronic Hepatitis B Infection: A Review","volume":"319","author":"Tang","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.intimp.2021.108182_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4254\/wjh.v10.i1.1","article-title":"Role of inflammatory response in liver diseases: therapeutic strategies","volume":"10","author":"Del Campo","year":"2018","journal-title":"World J. Hepatol."},{"issue":"3","key":"10.1016\/j.intimp.2021.108182_b0090","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jceh.2016.07.002","article-title":"Clinical Significance of quantitative HBsAg titres and its correlation with HBV DNA levels in the natural history of hepatitis B virus infection","volume":"6","author":"Karra","year":"2016","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.intimp.2021.108182_b0095","first-page":"320","article-title":"Decline of hepatitis B virus load correlate with increase of Th1\/Th2 immunity in chronic hepatitis B patients during long-term treatment with entecavir","volume":"21","author":"You","year":"2014","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.intimp.2021.108182_b0100","first-page":"174","article-title":"Effect of entecavir on CD4+ T-cell subpopulations in patients with chronic hepatitis B","volume":"15","author":"Tian","year":"2016","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.intimp.2021.108182_b0105","first-page":"111","article-title":"Dynamic changes of Th1\/Th2 type cytokines in peripheral blood in patients with HBeAg-positive chronic hepatitis B during telbivudine therapy","volume":"13","author":"Zhang","year":"2013","journal-title":"J. Practical Med."},{"issue":"6","key":"10.1016\/j.intimp.2021.108182_b0110","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/MEG.0000000000000854","article-title":"Development and validation of a prognostic model for acute-on-chronic hepatitis B liver failure","volume":"29","author":"Gao","year":"2017","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2021.108182_b0115","first-page":"37","article-title":"Changes of peripheral blood T lymphocyte subsets and serum cytokine levels in patients with chronic hepatitis B receiving lamivudine and kurorinone treatment","volume":"16","author":"Gong","year":"2013","journal-title":"J. Clin. Hepatol."},{"issue":"1","key":"10.1016\/j.intimp.2021.108182_b0120","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12016-014-8465-4","article-title":"Cytokine-mediated immunopathogenesis of hepatitis B virus infections","volume":"50","author":"Li","year":"2016","journal-title":"Clin. Rev. Allergy Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921008183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921008183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:50:12Z","timestamp":1778820612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921008183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":24,"alternative-id":["S1567576921008183"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108182","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of hepatitis B virus on T lymphocyte and its subsets in chronic hepatitis B patients in different ALT stages: A new concept ALT in HBV infection","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108182","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108182"}}